Utah Medical Products, Inc. (UTMD)
74.23
-0.83
(-1.11%)
USD |
NASDAQ |
Oct 23, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Utah Medical Products Net Income (Quarterly) : 2.787M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.787M |
| June 30, 2026 | 2.686M |
| March 31, 2026 | 2.604M |
| December 31, 2025 | 2.566M |
| September 30, 2025 | 2.631M |
| June 30, 2025 | 3.048M |
| March 31, 2025 | 3.041M |
| December 31, 2024 | 2.902M |
| September 30, 2024 | 3.563M |
| June 30, 2024 | 3.453M |
| March 31, 2024 | 3.956M |
| December 31, 2023 | 4.286M |
| September 30, 2023 | 3.935M |
| June 30, 2023 | 4.20M |
| March 31, 2023 | 4.214M |
| December 31, 2022 | 4.555M |
| September 30, 2022 | 4.28M |
| June 30, 2022 | 4.103M |
| March 31, 2022 | 3.534M |
| December 31, 2021 | 4.132M |
| September 30, 2021 | 4.206M |
| June 30, 2021 | 3.426M |
| March 31, 2021 | 3.024M |
| December 31, 2020 | 3.412M |
| September 30, 2020 | 2.933M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.313M |
| March 31, 2020 | 3.14M |
| December 31, 2019 | 4.358M |
| September 30, 2019 | 3.705M |
| June 30, 2019 | 3.525M |
| March 31, 2019 | 3.139M |
| December 31, 2018 | 3.393M |
| September 30, 2018 | 6.762M |
| June 30, 2018 | 4.308M |
| March 31, 2018 | 4.092M |
| December 31, 2017 | -2.522M |
| September 30, 2017 | 3.622M |
| June 30, 2017 | 3.87M |
| March 31, 2017 | 3.536M |
| December 31, 2016 | 2.717M |
| September 30, 2016 | 2.935M |
| June 30, 2016 | 3.259M |
| March 31, 2016 | 3.217M |
| December 31, 2015 | 3.21M |
| September 30, 2015 | 3.047M |
| June 30, 2015 | 2.918M |
| March 31, 2015 | 2.667M |
| December 31, 2014 | 3.00M |
| September 30, 2014 | 2.822M |
| June 30, 2014 | 2.834M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.621M |
| Total Expenses (Quarterly) | 5.834M |
| EPS Diluted (Quarterly) | 0.8763 |
| Enterprise Value | 150.66M |
| Gross Profit Margin (Quarterly) | 55.71% |
| Profit Margin (Quarterly) | 32.33% |
| Earnings Yield | 4.50% |
| Operating Earnings Yield | 4.50% |
| Normalized Earnings Yield | 4.557 |